Nicotine replacement therapy - a viable means of smoking cessation Vicky Hinstridge Newsletter Article 17 February 2013 Pages: 3 - 4
BW 566C - a candidate for addition to the antimalarial armamentarium Newsletter Article 17 February 2013 Pages: 5 - 5
Alteplase vs streptokinase assessed using a new cost-effectiveness model Newsletter Article 17 February 2013 Pages: 8 - 8
An insight into health economic research Steve Clissold Newsletter Article 17 February 2013 Pages: 9 - 9
Monotherapy as effective as combinations in febrile neutropenia Newsletter Article 17 February 2013 Pages: 16 - 16
Isotretinoin still prescribed frequently for women Newsletter Article 17 February 2013 Pages: 17 - 17
The risk of angioedema varies with different ACE inhibitors Newsletter Article 17 February 2013 Pages: 17 - 17
Antituberculars can be given safely with zidovudine Newsletter Article 17 February 2013 Pages: 17 - 18
Pfizer’s sertraline has a favourable safety profile Newsletter Article 17 February 2013 Pages: 18 - 18
The benefits of individualised aminoglycoside dosing Newsletter Article 17 February 2013 Pages: 18 - 19
The mechanism for tamoxifen-induced thrombophlebitis remains unclear Newsletter Article 17 February 2013 Pages: 19 - 19
The superiority of ACE inhibitors: effects on CAD risk reduction Newsletter Article 17 February 2013 Pages: 19 - 19